Keira Cohen

Research output

Research output per year 2003 2015 2016 2019 2020 2021 2023 2023

• 22 Article
• 7 Review article
• 3 Letter
• 1 Chapter
• 2 More
  • 1 Comment/debate
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2023

  Anatomic and Pathologic Causes of Recurrent Pulmonary Infections

  Harowicz, M. R., Khalifah, A. A., Cohen, K. A., Demaio, A., Illei, P. B., Fishman, E. K. & Lin, C. T., Jun 2023, In: Radiographics. 43, 6, e220106.

  Research output: Contribution to journal › Comment/debate › peer-review

• Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria An Official American Thoracic Society Workshop Report

  the Assembly on Pulmonary Infections and Tuberculosis, Mar 2023, In: Annals of the American Thoracic Society. 20, 3, p. 341-353 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Immunocompromised Host 100%
  • Pneumonia 76%
  • Thorax 64%
  • Education 59%
  • Biological Therapy 18%

• Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes

  Ghali, A. E., Morrisette, T., Alosaimy, S., Lucas, K., Tupayachi-Ortiz, M. G., Vemula, R., Wadle, C., Philley, J. V., Mejia-Chew, C., Hamad, Y., Stevens, R. W., Zeuli, J. D., Webb, A. J., Fiske, C. T., Simonyan, A., Cimino, C. L., Mammadova, M., Umana, V. E., Hasbun, R., Butt, S., & 13 othersMolina, K. C., Thomas, M., Kaip, E. A., Bouchard, J., Gore, T. W., Howard, C., Cabanilla, M. G., Holger, D. J., Frens, J. J., Barger, M., Ong, A., Cohen, K. A. & Rybak, M. J., Oct 2023, In: Antimicrobial agents and chemotherapy. 67, 10

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • omadacycline 100%
  • Nontuberculous Mycobacterium Infections 78%
  • Global Health 50%
  • Nontuberculous Mycobacteria 40%
  • Safety 29%

• Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease

  Dedrick, R. M., Smith, B. E., Cristinziano, M., Freeman, K. G., Jacobs-Sera, D., Belessis, Y., Brown, A. W., Cohen, K. A., Davidson, R. M., van Duin, D., Gainey, A., Garcia, C. B., George, C. R. R., Haidar, G., Ip, W., Iredell, J., Khatami, A., Little, J. S., Malmivaara, K., McMullan, B. J., & 15 othersMichalik, D. E., Moscatelli, A., Nick, J. A., Tupayachi Ortiz, M. G., Polenakovik, H. M., Robinson, P. D., Skurnik, M., Solomon, D. A., Soothill, J., Spencer, H., Wark, P., Worth, A., Schooley, R. T., Benson, C. A. & Hatfull, G. F., Jan 1 2023, In: Clinical Infectious Diseases. 76, 1, p. 103-112 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Phage Therapy 100%
  • Compassionate Use Trials 99%
  • Mycobacterium Infections 88%
  • Bacteriophages 64%
  • Pharmaceutical Preparations 27%
• 2022

  Nebulized Bacteriophage in a Patient with Refractory Mycobacterium abscessus Lung Disease

  Dedrick, R. M., Freeman, K. G., Nguyen, J. A., Bahadirli-Talbott, A., Cardin, M. E., Cristinziano, M., Smith, B. E., Jeong, S., Ignatius, E. H., Lin, C. T., Cohen, K. A. & Hatfull, G. F., Jul 1 2022, In: Open Forum Infectious Diseases. 9, 7, ofac194.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Mycobacterium abscessus 100%
  • Bacteriophages 65%
  • Lung Diseases 59%
  • Phage Therapy 33%
  • Mycobacterium 23%

• Treatment of Nontuberculous Mycobacterial Lung Disease Is Complex; Thus, Shared Decision Making Is Critical

  Marmor, M., Talbot, E. A. & Cohen, K. A., Aug 2022, In: Annals of the American Thoracic Society. 19, 8, p. 1265-1267 3 p.

  Research output: Contribution to journal › Short survey › peer-review
• 2021

  Global phylogenomic analyses of Mycobacterium abscessus provide context for non cystic fibrosis infections and the evolution of antibiotic resistance

  Bronson, R. A., Gupta, C., Manson, A. L., Nguyen, J. A., Bahadirli-Talbott, A., Parrish, N. M., Earl, A. M. & Cohen, K. A., Dec 1 2021, In: Nature communications. 12, 1, 5145.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • cystic fibrosis 100%
  • fibrosis 85%
  • Mycobacterium abscessus 84%
  • antibiotics 77%
  • infectious diseases 70%

• Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy

  Richter, W. J., Nguyen, J. A., Wu, A. E., Jennings, M. T., Lechtzin, N., Parrish, N. M., Psoter, K. J. & Cohen, K. A., May 2021, In: Journal of Cystic Fibrosis. 20, 3, p. 555-557 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection

  Dedrick, R. M., Freeman, K. G., Nguyen, J. A., Bahadirli-Talbott, A., Smith, B. E., Wu, A. E., Ong, A. S., Lin, C. T., Ruppel, L. C., Parrish, N. M., Hatfull, G. F. & Cohen, K. A., Aug 2021, In: Nature medicine. 27, 8, p. 1357-1361 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Nontuberculous Mycobacterium Infections 100%
  • Mycobacterium abscessus 98%
  • Refractory 67%
  • Neutralization 66%
  • Bacteriophages 64%

• Preliminary, Real-world, Multicenter Experience with Omadacycline for Mycobacterium abscessus Infections

  Morrisette, T., Alosaimy, S., Philley, J. V., Wadle, C., Howard, C., Webb, A. J., Veve, M. P., Barger, M. L., Bouchard, J., Gore, T. W., Lagnf, A. M., Ansari, I., Mejia-Chew, C., Cohen, K. A. & Rybak, M. J., Feb 1 2021, In: Open Forum Infectious Diseases. 8, 2, ofab002.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • omadacycline 100%
  • Nontuberculous Mycobacterium Infections 78%
  • Mycobacterium abscessus 25%
  • Lung 9%
  • Infections 8%

• Vitamin D deficiency is associated with increased nontuberculous mycobacteria risk in cystic fibrosis

  Richter, W. J., Sun, Y., Psoter, K. J., Santos, M. N., Nguyen, J. A., Sidhaye, A., Lechtzin, N., Jennings, M. T. & Cohen, K. A., May 2021, In: Annals of the American Thoracic Society. 18, 5, p. 913-916 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
• 2020

  Association of Mycobacterium africanum Infection with Slower Disease Progression Compared with Mycobacterium tuberculosis in Malian Patients with Tuberculosis

  Baya, B., Diarra, B., Diabate, S., Kone, B., Goita, D., Sarro, Y. D. S., Cohen, K., Holl, J. L., Achenbach, C. J., Tolofoudie, M., Togo, A. C. G., Sanogo, M., Kone, A., Kodio, O., Dabitao, D., Coulibaly, N., Siddiqui, S., Diop, S., Bishai, W., Dao, S., & 4 othersDoumbia, S., Murphy, R. L., Diallo, S. & Maiga, M., 2020, In: American Journal of Tropical Medicine and Hygiene. 102, 1, p. 36-41 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Mycobacterium africanum 100%
  • Mycobacterium Infections 75%
  • disease progression 71%
  • Mycobacterium tuberculosis 66%
  • tuberculosis 63%

• Evidence for expanding the role of streptomycin in the management of drug-resistant mycobacterium tuberculosis

  Cohen, K. A., Stott, K. E., Munsamy, V., Manson, A. L., Earl, A. M. & Pym, A. S., Sep 2020, In: Antimicrobial agents and chemotherapy. 64, 9, e00860-20.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multidrug-Resistant Tuberculosis 100%
  • Streptomycin 95%
  • Mycobacterium tuberculosis 80%
  • Amikacin 55%
  • Aminoglycosides 25%
  2 Scopus citations

• Getting to the point in point-of-care diagnostics for tuberculosis

  Ignatius, E. H., Cohen, K. A. & Bishai, W. R., Nov 2 2020, In: Journal of Clinical Investigation. 130, 11, p. 5671-5673 3 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Point-of-Care Systems 100%
  • Tuberculosis 73%
  • HIV 30%
  • lipoarabinomannan 22%
  • Urine 21%

• No amikacin, no problem: A Successful Treatment Approach for Pediatric Otomastoiditis Due to Amikacin-Resistant Mycobacterium abscessus

  Richter, W. J. & Cohen, K. A., 2020, In: Antimicrobial agents and chemotherapy. 64, 1, e02023-19.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Mycobacterium abscessus 100%
  • Amikacin 78%
  • Pediatrics 42%
  • Anti-Bacterial Agents 14%
  • Therapeutics 10%

• Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota

  Namasivayam, S., Diarra, B., Diabate, S., Sarro, Y. D. S., Kone, A., Kone, B., Tolofoudie, M., Baya, B., Diakite, M. T., Kodio, O., Cohen, K., Holl, J., Achenbach, C. J., Chatterjee, S., Murphy, R. L., Bishai, W., Diallo, S., Sher, A. & Maiga, M., May 2020, In: PLoS neglected tropical diseases. 14, 5, p. 1-20 20 p., e0008230.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Mycobacterium 100%
  • contagious disease 90%
  • Mycobacterium tuberculosis 90%
  • Microbiota 65%
  • Tuberculosis 54%
  2 Scopus citations
• 2019

  Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: Progress, promise, and challenges

  Cohen, K. A., Manson, A. L., Desjardins, C. A., Abeel, T. & Earl, A. M., Jul 25 2019, In: Genome Medicine. 11, 1, 45.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Whole Genome Sequencing 100%
  • Mycobacterium tuberculosis 83%
  • Drug Resistance 78%
  • Tuberculosis 42%
  • Antitubercular Agents 25%
  18 Scopus citations

• Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali

  Kone, A., Diarra, B., Cohen, K., Diabate, S., Kone, B., Diakite, M. T., Diarra, H., Sanogo, M., Togo, A. C. G., Sarro, Y. D. S., Baya, B., Coulibaly, N., Kodio, O., Achenbach, C. J., Murphy, R. L., Holl, J. L., Siddiqui, S., Doumbia, S., Bishai, W. R., Diallo, S., & 1 othersMaiga, M., Jan 2019, In: HLA. 93, 1, p. 24-31 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Mali 100%
  • Mycobacterium 75%
  • Gene Frequency 68%
  • Mycobacterium tuberculosis 68%
  • Tuberculosis 41%
  3 Scopus citations

• Extensive global movement of multidrug-resistant M. tuberculosis strains revealed by whole-genome analysis

  Cohen, K. A., Manson, A. L., Abeel, T., Desjardins, C. A., Chapman, S. B., Hoffner, S., Birren, B. W. & Earl, A. M., Sep 1 2019, In: Thorax. 74, 9, p. 882-889 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multidrug-Resistant Tuberculosis 100%
  • Genome 55%
  • Mycobacterium tuberculosis 26%
  • Information Dissemination 21%
  • Whole Genome Sequencing 21%
  11 Scopus citations
• 2018

  Mycobacterium abscessus and β-lactams: Emerging insights and potential opportunities

  Story-Roller, E., Maggioncalda, E. C., Cohen, K. A. & Lamichhane, G., Sep 25 2018, In: Frontiers in Microbiology. 9, SEP, 2273.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Mycobacterium abscessus 100%
  • Lactams 94%
  • Nontuberculous Mycobacterium Infections 33%
  • Anti-Bacterial Agents 29%
  • Nontuberculous Mycobacteria 28%
  10 Scopus citations
• 2017

  Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

  Manson, A. L., Cohen, K. A., Abeel, T., Desjardins, C. A., Armstrong, D. T., Barry, C. E., Brand, J., Chapman, S. B., Cho, S. N., Gabrielian, A., Gomez, J., Jodals, A. M., Joloba, M., Jureen, P., Lee, J. S., Malinga, L., Maiga, M., Nordenberg, D., Noroc, E., Romancenco, E., & 26 othersSalazar, A., Ssengooba, W., Velayati, A. A., Winglee, K., Zalutskaya, A., Via, L. E., Cassell, G. H., Dorman, S. E., Ellner, J., Farnia, P., Galagan, J. E., Rosenthal, A., Crudu, V., Homorodean, D., Hsueh, P. R., Narayanan, S., Pym, A. S., Skrahina, A., Swaminathan, S., Van Der Walt, M., Alland, D., Bishai, W. R., Cohen, T., Hoffner, S., Birren, B. W. & Earl, A. M., Mar 1 2017, In: Nature genetics. 49, 3, p. 395-402 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multidrug-Resistant Tuberculosis 100%
  • Multiple Drug Resistance 86%
  • Mycobacterium tuberculosis 80%
  • Molecular Pathology 62%
  • Rifampin 58%
  114 Scopus citations

• Mycobacterium abscessus L,D-transpeptidases are susceptible to inactivation by carbapenems and cephalosporins but not penicillins

  Kumar, P., Chauhan, V., Silva, J. R. A., Lameira, J., D’Andrea, F. B., Li, S. G., Ginell, S. L., Freundlich, J. S., Alves, C. N., Bailey, S., Cohen, K. A. & Lamichhane, G., 2017, In: Antimicrobial agents and chemotherapy. 61, 10

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Mycobacterium abscessus 100%
  • Peptidyl Transferases 97%
  • Lactams 94%
  • Carbapenems 76%
  • Cephalosporins 71%
  22 Scopus citations
• 2016

  Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance

  Desjardins, C. A., Cohen, K. A., Munsamy, V., Abeel, T., Maharaj, K., Walker, B. J., Shea, T. P., Almeida, D. V., Manson, A. L., Salazar, A., Padayatchi, N., O'Donnell, M. R., Mlisana, K. P., Wortman, J., Birren, B. W., Grosset, J., Earl, A. M. & Pym, A. S., May 1 2016, In: Nature genetics. 48, 5, p. 544-551 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cycloserine 100%
  • Mycobacterium tuberculosis 66%
  • Drug Resistance 31%
  • Alanine Dehydrogenase 30%
  • Pharmaceutical Preparations 28%
  88 Scopus citations

• Paradoxical Hypersusceptibility of Drug-resistant Mycobacterium tuberculosis to β-lactam Antibiotics

  Cohen, K. A., El-Hay, T., Wyres, K. L., Weissbrod, O., Munsamy, V., Yanover, C., Aharonov, R., Shaham, O., Conway, T. C., Goldschmidt, Y., Bishai, W. R. & Pym, A. S., 2016, In: EBioMedicine. 9, p. 170-179 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Clavulanate 100%
  • Lactams 81%
  • Amoxicillin 75%
  • Clavulanic Acid 73%
  • Multidrug-Resistant Tuberculosis 69%
  18 Scopus citations

• Stool microbiome reveals diverse bacterial ureases as confounders of oral urea breath testing for Helicobacter pylori and Mycobacterium tuberculosis in Bamako, Mali

  Maiga, M., Cohen, K., Baya, B., Srikrishna, G., Siddiqui, S., Sanogo, M., Somboro, A. M., Diarra, B., Diallo, M. H., Mazumdar, V., Yoder, C., Orsega, S., Belson, M., Kassambara, H., Goita, D., Murphy, R. L., Dao, S., Polis, M., Diallo, S., Timmins, G. S., & 3 othersDodd, L., Earl, A. M. & Bishai, W. R., Aug 17 2016, In: Journal of breath research. 10, 3, 036012.

  Research output: Contribution to journal › Article › peer-review

  • Mali 100%
  • Urease 87%
  • Microbiota 69%
  • Mycobacterium tuberculosis 68%
  • Helicobacter pylori 68%
  8 Scopus citations
• 2015

  Biomarkers for Tuberculosis Based on Secreted, Species-Specific, Bacterial Small Molecules

  Pan, S. J., Tapley, A., Adamson, J., Little, T., Urbanowski, M., Cohen, K., Pym, A., Almeida, D., Dorasamy, A., Layre, E., Young, D. C., Singh, R., Patel, V. B., Wallengren, K., Ndung'U, T., Wilson, D., Moody, D. B. & Bishai, W., 2015, In: Journal of Infectious Diseases. 212, 10, p. 1827-1834 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tuberculosis 100%
  • mycobactins 89%
  • Biomarkers 79%
  • Sputum 48%
  • Cerebrospinal Fluid 42%
  11 Scopus citations

• Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal

  Cohen, K. A., Abeel, T., Manson McGuire, A., Desjardins, C. A., Munsamy, V., Shea, T. P., Walker, B. J., Bantubani, N., Almeida, D. V., Alvarado, L., Chapman, S. B., Mvelase, N. R., Duffy, E. Y., Fitzgerald, M. G., Govender, P., Gujja, S., Hamilton, S., Howarth, C., Larimer, J. D., Maharaj, K., & 13 othersPearson, M. D., Priest, M. E., Zeng, Q., Padayatchi, N., Grosset, J., Young, S. K., Wortman, J., Mlisana, K. P., O'Donnell, M. R., Birren, B. W., Bishai, W. R., Pym, A. S. & Earl, A. M., Sep 2015, In: PLoS medicine. 12, 9, e1001880.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Extensively Drug-Resistant Tuberculosis 100%
  • Whole Genome Sequencing 78%
  • Mycobacterium tuberculosis 65%
  • Rifampin 53%
  • Disease Outbreaks 52%
  142 Scopus citations

• Evolution of extensively drug-resistant tuberculosis over four decades revealed by whole genome sequencing of Mycobacterium tuberculosis from KwaZulu-Natal, South Africa

  Cohen, K. A., Abeel, T., McGuire, A. M., Desjardins, C. A., Munsamy, V., Shea, T. P., Walker, B. J., Bantubani, N., Almeida, D. V., Alvarado, L., Chapman, S., Mvelase, N. R., Duffy, E. Y., Fitzgerald, M. G., Govender, P., Gujja, S., Hamilton, S., Howarth, C., Larimer, J. D., Maharaj, K., & 13 othersPearson, M. D., Priest, M. E., Zeng, Q., Padayatchi, N., Grosset, J., Young, S. K., Wortman, J., Mlisana, K. P., O'Donnell, M. R., Birren, B. W., Bishai, W. R., Pym, A. S. & Earl, A. M., 2015, (Accepted/In press) In: International Journal of Mycobacteriology.

  Research output: Contribution to journal › Article › peer-review

  • Extensively Drug-Resistant Tuberculosis 100%
  • Whole Genome Sequencing 78%
  • South Africa 70%
  • Mycobacterium tuberculosis 65%
  • Drug Resistance 61%

• Fatal nosocomial MDR TB identified through routine genetic analysis and whole-genome sequencing

  Martin Williams, O., Abeel, T., Casali, N., Cohen, K., Pym, A. S., Mungall, S. B., Desjardins, C. A., Banerjee, A., Drobniewski, F., Earl, A. M. & Cooke, G. S., 2015, In: Emerging infectious diseases. 21, 6, p. 1082-1084 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  10 Scopus citations

• Molecular basis of drug resistance in Mycobacterium tuberculosis

  Cohen, K. A., Bishai, W. R. & Pym, A. S., Oct 22 2015, Molecular Genetics of Mycobacteria. wiley, p. 411-429 19 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Mycobacterium tuberculosis 100%
  • Drug Resistance 93%
  • Strain 71%
  • Pharmaceutical Preparations 42%
  • Drug 36%
• 2014

  Efflux inhibition with verapamil potentiates bedaquiline in mycobacterium tuberculosis

  Gupta, S., Cohen, K. A., Winglee, K., Maiga, M., Diarra, B. & Bishai, W. R., Jan 2014, In: Antimicrobial agents and chemotherapy. 58, 1, p. 574-576 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • bedaquiline 100%
  • Verapamil 65%
  • Mycobacterium tuberculosis 59%
  • Clofazimine 45%
  • Pharmaceutical Preparations 25%
  107 Scopus citations

• Molecular basis of drug resistance in Mycobacterium tuberculosis

  Cohen, K. A., Bishai, W. R. & Pym, A. S., 2014, In: Microbiology Spectrum. 2, 3

  Research output: Contribution to journal › Review article › peer-review

  • drug resistance 100%
  • tuberculosis 86%
  • Mycobacterium tuberculosis 77%
  • antibiotics 64%
  • Drug Resistance 59%
  19 Scopus citations
• 2013

  Rising to the challenge: New therapies for tuberculosis

  Wong, E. B., Cohen, K. A. & Bishai, W. R., Sep 2013, In: Trends in Microbiology. 21, 9, p. 493-501 9 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Tuberculosis 100%
  • bedaquiline 99%
  • Poisons 45%
  • Pharmaceutical Preparations 37%
  • Drug Discovery 31%
  60 Scopus citations
• 2008

  Coadministration of oral levofloxacin with agents that impair absorption: Impact on antibiotic resistance

  Cohen, K. A., Lautenbach, E., Weiner, M. G., Synnestvedt, M. & Gasink, L. B., Oct 2008, In: Infection control and hospital epidemiology. 29, 10, p. 975-977 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluoroquinolones 91%
  • Microbial Drug Resistance 82%
  • Divalent Cations 49%
  • Cations 41%
  17 Scopus citations
• 2003

  Combined pars plana vitrectomy and lens management in complex vitreoretinal disease

  Chaudhry, N. A., Cohen, K. A., Flynn, H. W. & Murray, T. G., Sep 2003, In: Seminars in Ophthalmology. 18, 3, p. 132-141 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Temazepam 100%
  • Vitrectomy 93%
  • Lenses 79%
  • Cataract 65%
  • Cataract Extraction 51%
  29 Scopus citations